Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
Objective To study the incidence, predictors, and outcome of renal flares after successful
cyclophosphamide (CYC) treatment for diffuse proliferative glomerulonephritis (DPGN) in …
cyclophosphamide (CYC) treatment for diffuse proliferative glomerulonephritis (DPGN) in …
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
CC Mok, KY Ying, CW Yim, YP Siu, KH Tong… - Annals of the …, 2016 - ard.bmj.com
Objective To compare the efficacy of tacrolimus (TAC) and mycophenolate mofetil (MMF) for
the initial therapy of lupus nephritis (LN). Study design This is an open randomised …
the initial therapy of lupus nephritis (LN). Study design This is an open randomised …
Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide
CC Mok, KY Ying, WL Ng, KW Lee, CH To… - The American journal of …, 2006 - Elsevier
PURPOSE: To report the long-term outcome of diffuse proliferative lupus nephritis (DPLN)
treated with cyclophosphamide (CYC) in Chinese patients. METHODS: Patients with biopsy-…
treated with cyclophosphamide (CYC) in Chinese patients. METHODS: Patients with biopsy-…
Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial
CC Mok, KY Ying, CH To, LY Ho, KL Yu… - Annals of the …, 2011 - ard.bmj.com
Objectives To study the efficacy of raloxifene in preventing bone mineral density (BMD) loss
in women receiving long-term glucocorticoids (GC). The study took the form of a parallel-…
in women receiving long-term glucocorticoids (GC). The study took the form of a parallel-…
Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial
Background: The aim of this study was to report the outcome of pure membranous lupus
nephropathy treated with prednisone and azathioprine (AZA). Methods: Consecutive patients …
nephropathy treated with prednisone and azathioprine (AZA). Methods: Consecutive patients …
Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis—a randomized trial
…, S Wang, RJ Li, KL Lee, YY Leung, KY Ying… - The Journal of …, 2012 - jrheum.org
Objective. To determine the efficacy of methotrexate (MTX) with infliximab (IFX) compared
with MTX alone in the prevention of atherosclerosis and arterial stiffness in patients with early …
with MTX alone in the prevention of atherosclerosis and arterial stiffness in patients with early …
IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study
…, S Wang, RJ Li, KL Lee, YY Leung, KY Ying… - Seminars in arthritis and …, 2015 - Elsevier
Objectives To study the association between the baseline IL-33 and soluble ST2 (sST2)
levels with disease remission and progression of carotid atherosclerosis in early rheumatoid …
levels with disease remission and progression of carotid atherosclerosis in early rheumatoid …
Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis—a prospective study
…, S Wong, RJ Li, KL Lee, YY Leung, KY Ying… - Seminars in Arthritis and …, 2013 - Elsevier
OBJECTIVE: We assessed whether a serum soluble receptor for advanced glycation end
product (sRAGE) levels were associated with a progression of carotid atherosclerosis and …
product (sRAGE) levels were associated with a progression of carotid atherosclerosis and …
Clinical presentation, treatment and outcome of Takayasu's arteritis in southern Chinese: a multicenter retrospective study
To study the clinical presentation, treatment and outcome of southern Chinese patients with
Takayasu’s arteritis (TA). This is a retrospective chart review study of 78 patients managed in …
Takayasu’s arteritis (TA). This is a retrospective chart review study of 78 patients managed in …
Disease modifying anti-rheumatic drugs: review on pregnancy and lactation
TY wu, KY Ying - Journal of Clinical Rheumatology and Immunology, 2019 - World Scientific
Rheumatic diseases occur commonly in patients of childbearing age. The compatibility of
different Disease Modifying Anti-Rheumatic Drugs (DMARDs) during pregnancy and lactation …
different Disease Modifying Anti-Rheumatic Drugs (DMARDs) during pregnancy and lactation …